<DOC>
	<DOC>NCT01335412</DOC>
	<brief_summary>This is an active electronic surveillance using data from the Defense Medical Surveillance System (DMSS) to detect and characterize serious, rare adverse events occurring within 42 days after vaccination with the Japanese Encephalitis Vaccine IXIARO within the US Military, to detect adverse events that occur more frequently after IXIARO and to electronically follow up pregnancies during or shortly before which IXIARO was administered. There will be no intervention and no individuals contacted.</brief_summary>
	<brief_title>Safety Surveillance After Immunization With IXIARO</brief_title>
	<detailed_description />
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Encephalitis, Japanese</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Male and female active duty U.S. military personnel â‰¥ 17 years of age who either received at least one dose of IXIARO (IXIARO exposed group) or at least one dose of JEVAX (comparison group). Individuals who have an ICD9CM code suggestive of one of the predefined adverse events screened for in IC51401 prior to vaccination with IXIARO cannot with certainty be classified as being "disease free" at study entry and will be excluded for that adverse event.</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>